• Assessment of likely revenue potential for several marketed products in the AI and CNS areas including the assessment of potential and preparation of investment decisions for line extensions in areas such as Post Traumatic Stress Disorder (PTSD), Premenstrual Dysphoric Disorder (PMDD), recurrent sinusitis and otitis media, laser dermabrasion, hepatitis B and others.
• Preparation of market analyses and investment decisions in several FMCG areas such as fruit juices, muesli bars, probiotics and vitamins.
• Preparation of divest, out-licensing and leverage recommendations on products in tail of portfolio of UK pharma organisation.

back